Astrocytoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 33: | Line 33: | ||
|- | |- | ||
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |Adult primary brain tumors | | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |Adult primary brain tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Glioblastoma multiforme | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glioblastoma multiforme]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− | ||
Line 69: | Line 69: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Oligodendroglioma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Oligodendroglioma]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− | ||
Line 95: | Line 95: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Meningioma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Meningioma]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− | ||
Line 122: | Line 122: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemangioblastoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemangioblastoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− | ||
Line 146: | Line 146: | ||
* May be associated with von hippel-lindau syndrome | * May be associated with von hippel-lindau syndrome | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pituitary adenoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | − | | style="background: #F5F5F5; padding: 5px;" | − | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
Line 166: | Line 166: | ||
* May be associated with NF-2 (bilateral schwannomas) | * May be associated with NF-2 (bilateral schwannomas) | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Schwannoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Schwannoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | − | | style="background: #F5F5F5; padding: 5px;" | − | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
Line 177: | Line 177: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Split-fat sign | |||
* Fascicular sign | |||
* Often have areas of hemosiderin | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Schwann cell origin | * Schwann cell origin | ||
Line 185: | Line 188: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Primary CNS lymphoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Primary central nervous system lymphoma|Primary CNS lymphoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− | ||
Line 208: | Line 211: | ||
|- | |- | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |Childhood primary brain tumors | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |Childhood primary brain tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pilocytic astrocytoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pilocytic astrocytoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− | ||
Line 232: | Line 235: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Medulloblastoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Medulloblastoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− | ||
Line 256: | Line 259: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Ependymoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ependymoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− | ||
Line 304: | Line 307: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pinealoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pinealoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px;" | +/− |
Revision as of 15:55, 18 January 2019
Astrocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Study |
Astrocytoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Astrocytoma differential diagnosis |
Risk calculators and risk factors for Astrocytoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Differentiating astrocytoma from other Diseases
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||
Lab Findings | Imaging | Immunohistopathology | ||||||||||||
Headache | Seizure | Visual disturbance | Hearing loss | Constitutional | Extraocular movement disorder | Focal neurologic deficit | Endocrine abnormalities | CT scan | MRI | |||||
Adult primary brain tumors | Glioblastoma multiforme | + | +/− | +/− | − | − | + | − |
|
|
|
|||
Oligodendroglioma | + | +/− | +/− | − | − | + | − |
|
|
|
||||
Meningioma | + | +/− | +/− | − | − | + | − |
|
|
|
||||
Hemangioblastoma | + | +/− | +/− | − | − | + | − |
|
|
|
| |||
Pituitary adenoma | − | − | + Bitemporal hemianopia | − | − | − |
|
|
|
|
| |||
Schwannoma | − | − | +/− | + | − | − |
|
|
|
|||||
Primary CNS lymphoma | + | +/− | +/− | − | − | − |
|
|
|
|||||
Childhood primary brain tumors | Pilocytic astrocytoma | + | +/− | +/− | − | − | − |
|
|
|
||||
Medulloblastoma | + | +/− | +/− | − | − | − |
|
|
|
|||||
Ependymoma | + | +/− | +/− | − | − | − |
|
|
|
|||||
Craniopharyngioma | + | +/− | + Bitemporal hemianopia | − | − |
|
|
|
|
|||||
Pinealoma | + | +/− | +/− | − | − | + vertical gaze palsy | + |
|
|
|
|
|||
Vascular | AV malformation | + | + | − | ||||||||||
Brain aneurysm | + | − | ||||||||||||
Infectious | Bacterial brain abscess | + | + | |||||||||||
Tuberculosis | + | + | ||||||||||||
Toxoplasmosis | + |
|
||||||||||||
Hydatid cyst | + | |||||||||||||
Fungal | + | |||||||||||||
Other | Brain metastasis | + |
|